Literature DB >> 3024880

Immunological abnormalities in intravenous drug abusers and relationship to the prolonged generalized lymphadenopathy syndrome in Italy.

P De Paoli, M Reitano, S Battistin, P Martelli, D Villalata, F Bergamo, U Tirelli, A Carbone, S Diodato, R Bosio.   

Abstract

The prolonged generalized lymphadenopathy syndrome (PGL) has been considered a prodromal condition to the Acquired immunodeficiency syndrome (AIDS), but the clinical, virological and immunological characteristics of patients who will develop AIDS are not known. We report on the immunological profile of intravenous drug abusers with or without PGL in Northeastern Italy. We found a reduction of lymphocyte-absolute numbers with reversal of the T4/T8 ratio and decreased Leu-11b+ cells. The response to mitogens and natural killer activity are compromised in PGL patients. Neutrophil function is reduced both in drug abusers with or without lymphadenopathy. The serological investigations revealed a high prevalence of antibodies against HTLV III and the Epstein-Barr viruses. The recognition of immune dysfunction in the intravenous drug abusers appears to be important since these patients develop AIDS and these abnormalities may precede AIDS.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024880      PMCID: PMC1542450     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

Review 1.  AIDS--an immunologic reevaluation.

Authors:  M Seligmann; L Chess; J L Fahey; A S Fauci; P J Lachmann; J L'Age-Stehr; J Ngu; A J Pinching; F S Rosen; T J Spira
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

Review 2.  Immune function and dysfunction in AIDS.

Authors:  F P Siegal
Journal:  Semin Oncol       Date:  1984-03       Impact factor: 4.929

Review 3.  The acquired immune deficiency syndrome.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

4.  Altered T-lymphocyte subsets in hospitalized intravenous drug abusers.

Authors:  J Layon; A Idris; M Warzynski; R Sherer; D Brauner; O Patch; D McCulley; P Orris
Journal:  Arch Intern Med       Date:  1984-07

5.  An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction.

Authors:  H Masur; M A Michelis; J B Greene; I Onorato; R A Stouwe; R S Holzman; G Wormser; L Brettman; M Lange; H W Murray; S Cunningham-Rundles
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

6.  The syndrome of unexplained generalized lymphadenopathy in young men in New York City. Is it related to the acquired immune deficiency syndrome?

Authors:  B Miller; S K Stansfield; M M Zack; J W Curran; J E Kaplan; L B Schonberger; H Falk; T J Spira; D Mildvan
Journal:  JAMA       Date:  1984-01-13       Impact factor: 56.272

7.  Opportunistic infections and immune deficiency in homosexual men.

Authors:  D Mildvan; U Mathur; R W Enlow; P L Romain; R J Winchester; C Colp; H Singman; B R Adelsberg; I Spigland
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

8.  Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions.

Authors:  F P Siegal; C Lopez; G S Hammer; A E Brown; S J Kornfeld; J Gold; J Hassett; S Z Hirschman; C Cunningham-Rundles; B R Adelsberg
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

9.  Purified human monocyte subsets as effector cells in antibody-dependent cellular cytotoxicity (ADCC).

Authors:  D L McCarley; V O Shah; R S Weiner
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

10.  Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody.

Authors:  A B Tilden; T Abo; C M Balch
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

View more
  1 in total

1.  In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.

Authors:  J Chehimi; S Bandyopadhyay; K Prakash; B Perussia; N F Hassan; H Kawashima; D Campbell; J Kornbluth; S E Starr
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.